GlassScriptPhysician profile
Allison H Lee
NPI 1417320102
$7,316.76
in general payments reported to CMS, 2019-2025
32 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,391 · 2022: $1,538 · 2023: $1,729 · 2024: $1,495 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,030 · Travel and Lodging: $189 · Education: $138 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,029.61 |
| Travel and Lodging | $189.28 |
| Education | $137.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $934.83 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $917.94 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $823.46 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $674.28 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $550.23 | 2021-2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $425.09 | 2021-2025 | Provenge |
| Medtronic, INC. | $398.03 | 2021-2025 | Interstim |
| Axonics, INC. | $376.90 | 2022-2024 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $348.64 | 2021-2025 | Lynparza, Keytruda, Welireg |
| Myovant Sciences INC. | $292.06 | 2021-2022 | |
| Janssen Biotech, INC. | $266.28 | 2021-2025 | Erleada |
| Urogen Pharma, INC. | $220.25 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $103.04 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $96.18 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $95.63 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $88.52 | 2021-2024 | |
| 180 Medical, INC. | $81.06 | 2022-2024 | Gentlecath |
| Pfizer INC. | $79.66 | 2021-2025 | |
| Boston Scientific Corporation | $67.87 | 2022-2023 | Rezum Generator |
| Ferring Pharmaceuticals INC. | $57.30 | 2024-2025 | Adstiladrin |
| Urovant Sciences INC | $55.98 | 2021-2022 | |
| Immunitybio, INC. | $49.79 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $46.28 | 2021 | |
| Verity Pharmaceuticals INC. | $44.93 | 2022-2023 | Trelstar |
| Tolmar, INC. | $32.94 | 2024-2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $32.31 | 2021 | |
| Convatec INC. | $32.00 | 2021 | |
| Alnylam Pharmaceuticals INC. | $28.90 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $27.85 | 2022-2023 | Lynparza |
| Blue Earth Diagnostics | $27.11 | 2021 | |
| Rochester Medical Corporation | $22.52 | 2021 | |
| Hollister Incorporated | $18.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.